OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
Randomised trials lie at the heart of the practice of evidence-based clinical medicine. Over the last 40 years, results from large randomised trials have led to widespread use of effective cardio-protective drugs and the avoidance of millions of premature deaths and non-fatal major vascular events.
Examples from lipid-lowering and diabetes trials which have had an important impact will be used to illustrate evolving methods for delivering streamlined and cost-effective trials that answer important clinical questions. Wider dissemination of such methods is essential to ensure that late phase trials remain viable in the light of the rising costs and complexity of trials run by the pharmaceutical industry.
